Cortexyme Inc (CRTX) Dividend History
CORNERSTONE THERAPEUTICS is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription products for the respiratory market. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a deep late-stage clinical pipeline with six regulatory approval submissions expected between 2009 and 2010. The Company's commercial strategy is to grow market share for its currently marketed products using its sales and marketing capabilities, acquire non-promoted or underperforming branded pharmaceutical products and implement life cycle management techniques to maximize the value of its currently marketed products, newly acquired products and product candidates that are in development.
Last update 05/26/2022
Dividend Yield Summary
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Dividends |
- |
- |
- |
- |
- |
- |
| Average Price |
- |
- |
30.33 |
46.21 |
47.13 |
5.80 |
| Yield |
- |
- |
- |
- |
- |
- |
• The above Dividend, Average Price, and Yield values for 2022 are year-to-date.
DivInfo Metrics ™
| 52-Week Projected Earnings Per Share |
0.00 |
| 52-Week Projected Dividends Per Share |
0.00 |
| Dividend Cover |
- |
| 52-Week Projected Yield |
- |
| 52-Week Trailing Yield |
- |
| 6-Year Average Yield |
- |
| 6-Year Dividend Change |
- |
| 6-Year Yearly Dividend Change |
- |
|
Number of Dividend Payments
(2008-09-15 - 2008-09-15)
|
1 |
Dividend History
| Date |
Amount Per Share |
Note |
| 2008-09-15 |
$0.55 |
|
